Old Web
English
Sign In
Acemap
>
authorDetail
>
Fedor Hlebokazov
Fedor Hlebokazov
Epilepsy
Internal medicine
Standard treatment
Mesenchymal stem cell
Cell therapy
2
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical benefits of single vs repeated courses of mesenchymal stem cell therapy in epilepsy patients.
2021
Clinical Neurology and Neurosurgery
Fedor Hlebokazov
Tatiana Dakukina
M. P. Potapnev
S. M. Kosmacheva
Lubov Moroz
Nikolai Misiuk
Tatiana Golubeva
Elena Slobina
Olga Krasko
Antos Shakhbazau
Ivan Hlavinski
Natalia V. Goncharova
Show All
Source
Cite
Save
Citations (0)
Treatment of refractory epilepsy patients with autologous mesenchymal stem cells reduces seizure frequency: An open label study
2017
Advances in Medical Sciences
Fedor Hlebokazov
Tatiana Dakukina
Svetlana Ihnatsenko
S. M. Kosmacheva
Michael Potapnev
Antos Shakhbazau
Natalia V. Goncharova
Michael Makhrov
Pavel Korolevich
Nikolai Misyuk
Victoria Dakukina
Irina Shamruk
Elena Slobina
Sergei Marchuk
Show All
Source
Cite
Save
Citations (18)
1